The UN General Assembly adopted today with the support of 184 of its member states a new resolution calling for the end of the economic, commercial and financial blockade imposed by the United States against Cuba.
Cuban health authorities announced the diagnoses of 2055 people with COVID-19 infections after its molecular bio9logy laboratories processed 30 462 samples for PCR tests.
The international demand to put an end to the United States blockade against Cuba on Wednesday once again tops the agenda of the UN General Assembly, which has already expressed its rejection to that mechanism on 28 previous occasions.
With more than 100 innovation projects, the Cuban Group of Biotechnological and Pharmaceutical Industries (BioCubaFarma) currently continues with the development of new medications, despite the United States blockade against the Caribbean nation.
Results from the trial of Cuba anti-Covid-19 vaccine candidate Soberana 02 are out. Its two-dose immunization scheme, after its Phase III trial, has achieved 62 percent efficacy, manufacturer BioCubaFarma announced Saturday.